Health Condition 1: L910- Hypertrophic scar
Conditions
Interventions
Intervention1: CO2 laser assisted macro coring: CO2 laser assisted macro coring of keloid tissue using a 1 to 2 mm probe spaced 1 mm apart, followed by intralesional triamcinolone acetonide injection
Sponsors
CUTIS Academy of Cutaneous Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of either gender, above the age of 15to 70 years (guardians consent). 2.Patients having single or multiple clinically diagnosed keloids. 3.Patients having keloids over any region of the body. 4.Duration of lesions more than 6 months. 5.Patients not on any surgical treatment for the past 3 months. 6.Patients consenting for study and willing for follow up.
Exclusion criteria
Exclusion criteria: 1. Patients with infected keloids or coexisting inflammatory systemic skin diseases 2. Unrealistic expectations or psychiatric illnesses 3. Pre existing bleeding disorders 4. Lactating/pregnant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in keloid volume from baseline to 12 weeks, measured using 3D profilometry-derived volume metrics via Antera 3D Imaging System (Miravex, Ireland).Timepoint: After Week 12 | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in keloid surface texture, vascularity, and pigmentation will be objectively assessed using Antera 3D imaging. Clinician assessments will include the Vancouver Scar Scale and POSAS Observer Scale, while patient feedback will be recorded using the POSAS Patient Scale, VAS for pain and itch, and a satisfaction Likert scale. Recurrence and time to recurrence will also be monitored through Antera 3D parameters during follow-up.Timepoint: After Week 12 | — |
Countries
India
Contacts
Public ContactDr Madura C
CUTIS Academy of Cutaneous Sciences
Outcome results
None listed